SHIEF
Shield Therapeutics plc
SHIEF
Shield Therapeutics plc
Shield Therapeutics plc (SHIEF) Discusses Strategic Acquisition of Full U.S. Commercial Control of ACCRUFeR Transcript
Shares in Shield Therapeutics PLC (AIM:STX, OTCQB:SHIEF) rose 11% to 4.89p on Thursday after the pharmaceutical company reported sharply narrower half-year losses and reaffirmed its aim of reaching op
Shield Therapeutics PLC (AIM:STX, OTCQB:SHIEF) told investors it remained profitable in the first half as a China milestone payment and higher royalties lifted revenue 41% to $30.4 million, with the c